Edition:
United Kingdom

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

15.15USD
13 Aug 2018
Change (% chg)

-- (--)
Prev Close
$15.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
60,146
52-wk High
$20.55
52-wk Low
$7.30

Chart for

About

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing oncology therapeutics. The Company is developing approximately three clinical stage product candidates, including SL-401, SL-701 and SL-801. SL-401 is a targeted therapy directed to the... (more)

Overall

Beta: -0.12
Market Cap(Mil.): $302.10
Shares Outstanding(Mil.): 25.28
Dividend: --
Yield (%): --

Financials

  STML.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -2.44 -- --
ROI: -65.15 1.78 14.61
ROE: -65.34 3.28 16.33

BRIEF-Stemline Therapeutics Reports Q1 Loss Per Share $0.69

* STEMLINE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

BRIEF-Stemline Therapeutics Inc - Co Launched An At-Market Offering Of Up To $50 Million Worth Of Shares

* STEMLINE THERAPEUTICS INC - ‍ON MARCH 16, 2018, CO LAUNCHED AN AT--MARKET OFFERING OF UP TO $50 MILLION WORTH OF SHARES OF COMPANY'S COMMON STOCK​ Source text (http://bit.ly/2HHHaYN) Further company coverage: (Reuters.Brief@thomsonreuters.com)

16 Mar 2018

BRIEF-Stemline Therapeutics Q4 Loss Per Share $0.93

* STEMLINE THERAPEUTICS REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS

16 Mar 2018

Competitors

  Price Chg
Astellas Pharma Inc (4503.T) ¥1,869 +23.00
Eisai Co., Ltd (4523.T) ¥9,707 +233.00
Sumitomo Dainippon Pharma Co Ltd (4506.T) ¥2,186 +50.00
Pfizer Inc. (PFE.N) $40.78 -0.03
Novartis AG (NOVN.S) CHF81.52 -0.16
Merck & Co., Inc. (MRK.N) $66.58 -0.14
Roche Holding Ltd. (ROG.S) CHF239.50 +1.35
Roche Holding Ltd. (RO.S) CHF243.00 0.00
Sanofi SA (SASY.PA) €72.85 -0.64
GlaxoSmithKline plc (GSK.L) 1,560.00 +9.20

Earnings vs. Estimates